CY1112711T1 - ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΠΑΡΑΓΩΓΩΝ ΚΥΚΛΟΠΕΝΤΑ[g]ΚΙΝΑΖΟΛΙΝΗΣ - Google Patents
ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΠΑΡΑΓΩΓΩΝ ΚΥΚΛΟΠΕΝΤΑ[g]ΚΙΝΑΖΟΛΙΝΗΣInfo
- Publication number
- CY1112711T1 CY1112711T1 CY20111101068T CY111101068T CY1112711T1 CY 1112711 T1 CY1112711 T1 CY 1112711T1 CY 20111101068 T CY20111101068 T CY 20111101068T CY 111101068 T CY111101068 T CY 111101068T CY 1112711 T1 CY1112711 T1 CY 1112711T1
- Authority
- CY
- Cyprus
- Prior art keywords
- cyclopenta
- kinazolin
- producers
- production
- formula
- Prior art date
Links
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000003277 amino group Chemical group 0.000 abstract 2
- 125000004104 aryloxy group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- BCCZFOXKKDTUTF-UHFFFAOYSA-N 5h-cyclopenta[g]quinazoline Chemical class C1=NC=C2CC3=CC=CC3=CC2=N1 BCCZFOXKKDTUTF-UHFFFAOYSA-N 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/16—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Paints Or Removers (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Κυκλοπεντα[g]κιναζολίνες του τύπου (Ι) και εστέρες και αμίδια αυτών μπορεί να κατασκευάζονται με αντίδραση εστέρα ή αμιδίου του τύπου (ΙΙ) ή προστατευμένου παραγώγου αυτού με ένα σύμπλοκο που περιέχει το (προπαργύλ)Co2(CO)6+ιόν.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0121214.1A GB0121214D0 (en) | 2001-08-31 | 2001-08-31 | Synthetic method |
US34024401P | 2001-12-18 | 2001-12-18 | |
EP02755271A EP1421069B1 (en) | 2001-08-31 | 2002-08-30 | Process for the preparation of cyclopenta[g]quinazoline derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1112711T1 true CY1112711T1 (el) | 2016-02-10 |
Family
ID=9921361
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20111101068T CY1112711T1 (el) | 2001-08-31 | 2011-11-07 | ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΠΑΡΑΓΩΓΩΝ ΚΥΚΛΟΠΕΝΤΑ[g]ΚΙΝΑΖΟΛΙΝΗΣ |
Country Status (11)
Country | Link |
---|---|
US (1) | US7250511B2 (el) |
EP (2) | EP2213664B1 (el) |
JP (2) | JP4405798B2 (el) |
AT (1) | ATE519747T1 (el) |
CY (1) | CY1112711T1 (el) |
DK (2) | DK1421069T3 (el) |
ES (1) | ES2371334T3 (el) |
GB (1) | GB0121214D0 (el) |
HK (1) | HK1145321A1 (el) |
PT (1) | PT1421069E (el) |
WO (1) | WO2003020706A1 (el) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60311101T2 (de) * | 2002-07-09 | 2007-06-21 | Actelion Pharmaceuticals Ltd. | 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido und 2,3-dihydro-2h-pyrrolo (2,1-b)-chinazolinon-derivate |
US7799832B2 (en) | 2003-10-23 | 2010-09-21 | Valeant Pharmaceuticals North America | Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains |
US7960436B2 (en) | 2006-06-05 | 2011-06-14 | Valeant Pharmaceuticals International | Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators |
US8993593B2 (en) | 2006-08-23 | 2015-03-31 | Valeant Pharmaceuticals International | N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators |
US8293911B2 (en) | 2006-08-23 | 2012-10-23 | Valeant Pharmaceuticals International | Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
US8722929B2 (en) | 2006-10-10 | 2014-05-13 | Valeant Pharmaceuticals International | N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators |
EA200900749A1 (ru) | 2006-11-28 | 2009-12-30 | Валеант Фармасьютикалс Интернэшнл | 1,4-диаминобициклические аналоги ретигабина как модуляторы калиевых каналов |
US8367684B2 (en) | 2007-06-13 | 2013-02-05 | Valeant Pharmaceuticals International | Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators |
US8563566B2 (en) | 2007-08-01 | 2013-10-22 | Valeant Pharmaceuticals International | Naphthyridine derivatives as potassium channel modulators |
US7786146B2 (en) | 2007-08-13 | 2010-08-31 | Valeant Pharmaceuticals International | Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
BR112013001350A2 (pt) | 2010-07-19 | 2016-05-17 | Onyx Pharma Inc | síntese de ciclopentaquinazolina |
JP2014513663A (ja) * | 2010-12-22 | 2014-06-05 | オニックス ファーマシューティカルズ,インコーポレイティド | 効率的なペプチドカップリングおよびシクロペンタ[g]キナゾリン3ナトリウム塩の合成および単離でのそれらの使用 |
US9717797B2 (en) | 2013-12-05 | 2017-08-01 | International Business Machines Corporation | Polycarbonates bearing aromatic N-heterocycles for drug delivery |
GB201707864D0 (en) | 2017-05-16 | 2017-06-28 | Inst Of Cancer Research: Royal Cancer Hospital | Platinum-reistant cancer treatment |
CR20220250A (es) | 2019-11-08 | 2022-08-19 | Xenon Pharmaceuticals Inc | Métodos para el tratamiento de trastornos depresivos |
MX2023009314A (es) | 2021-02-09 | 2023-08-16 | Xenon Pharmaceuticals Inc | Apertura del canal de potasio dependiente de voltaje para usarse en el tratamiento de la anhedonia. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9223352D0 (en) | 1992-11-06 | 1992-12-23 | Ici Plc | Tricyclic compounds |
GB9408936D0 (en) | 1994-05-05 | 1994-06-22 | Cancer Res Inst | Anti-cancer compounds |
GB9904275D0 (en) | 1999-02-24 | 1999-04-21 | Cancer Res Campaign Tech | Anti-cancer compounds |
GB9913083D0 (en) * | 1999-06-04 | 1999-08-04 | Novartis Ag | Organic compounds |
DE60110896T2 (de) * | 2000-01-18 | 2006-01-12 | Novartis Ag | Carboxamide und ihre verwendung als inhibitoren des mikrosomalen triglycerid-transfer-proteins und der apolipoprotein b (apo b) sekretion |
-
2001
- 2001-08-31 GB GBGB0121214.1A patent/GB0121214D0/en not_active Ceased
-
2002
- 2002-08-30 EP EP10003257.2A patent/EP2213664B1/en not_active Expired - Lifetime
- 2002-08-30 AT AT02755271T patent/ATE519747T1/de active
- 2002-08-30 US US10/487,863 patent/US7250511B2/en not_active Expired - Lifetime
- 2002-08-30 EP EP02755271A patent/EP1421069B1/en not_active Expired - Lifetime
- 2002-08-30 DK DK02755271.0T patent/DK1421069T3/da active
- 2002-08-30 DK DK10003257.2T patent/DK2213664T3/da active
- 2002-08-30 PT PT02755271T patent/PT1421069E/pt unknown
- 2002-08-30 WO PCT/GB2002/003967 patent/WO2003020706A1/en active Search and Examination
- 2002-08-30 ES ES02755271T patent/ES2371334T3/es not_active Expired - Lifetime
- 2002-08-30 JP JP2003524977A patent/JP4405798B2/ja not_active Expired - Lifetime
-
2009
- 2009-08-21 JP JP2009192490A patent/JP5275945B2/ja not_active Expired - Lifetime
-
2010
- 2010-12-13 HK HK10111597.2A patent/HK1145321A1/xx not_active IP Right Cessation
-
2011
- 2011-11-07 CY CY20111101068T patent/CY1112711T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2005507384A (ja) | 2005-03-17 |
US20040266798A1 (en) | 2004-12-30 |
WO2003020706A1 (en) | 2003-03-13 |
EP2213664A1 (en) | 2010-08-04 |
EP1421069A1 (en) | 2004-05-26 |
EP2213664B1 (en) | 2014-04-30 |
DK2213664T3 (da) | 2014-07-21 |
DK1421069T3 (da) | 2011-11-21 |
EP1421069B1 (en) | 2011-08-10 |
US7250511B2 (en) | 2007-07-31 |
JP2009280609A (ja) | 2009-12-03 |
GB0121214D0 (en) | 2001-10-24 |
PT1421069E (pt) | 2011-11-21 |
ES2371334T3 (es) | 2011-12-29 |
JP5275945B2 (ja) | 2013-08-28 |
JP4405798B2 (ja) | 2010-01-27 |
ATE519747T1 (de) | 2011-08-15 |
HK1145321A1 (en) | 2011-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1112711T1 (el) | ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΠΑΡΑΓΩΓΩΝ ΚΥΚΛΟΠΕΝΤΑ[g]ΚΙΝΑΖΟΛΙΝΗΣ | |
ATE289608T1 (de) | Herstellung von camptothecinderivaten durch intramolekulare cyclisierung | |
DE69415319D1 (de) | Verfahren zur herstellung von piperidinderivaten | |
DE69801764D1 (de) | Verfahren zur herstellung von citalopram | |
NO303574B1 (no) | Ny fremgangsmÕte for fremstilling av 9-amino-6-demetyl-6-deoksytetracykliner | |
DE60306667D1 (de) | Cefdinir salze als zwischenprodukte | |
ATE202087T1 (de) | Verfahren zur herstellung von 4-substituierten azetidinon-derivaten | |
ATE356815T1 (de) | Herstellung von perylen-3,4-dicarbonsäure- anhydriden | |
DK0388188T3 (da) | Benzoxepinderivater | |
ATE208381T1 (de) | Verfahren zur herstellung von taxol und seiner derivate | |
WO2002059089A3 (en) | Process for the preparation of heterocyclic indene analogs | |
HK1052001A1 (en) | A process for the preparation of alpha-chloroketones | |
EP1227081A4 (en) | PROCESS FOR THE PREPARATION OF OXYMINOALKANOIC ACID DERIVATIVES | |
EP1431278A4 (en) | METHOD FOR PRODUCING (2-NITROPHENYL) ACETONITRILE DERIVATIVES AND ASSOCIATED INTERMEDIATES | |
WO2001007439A3 (en) | Process for the production of epothiolone b and derivatives as well as intermediate products for this process | |
ATE478837T1 (de) | Verfahren zur herstellung von benzylaminderivaten | |
ATE364600T1 (de) | Verfahren zur herstellung von indol-derivaten und intermediaten dafür | |
WO2003004464A3 (de) | Heterozyklische amidderivate und deren verwendung als schädlingsbekämpfungsmittel | |
AU2003298136A1 (en) | Cyanomethyl trithiocarbonates as nematicides | |
WO2001018231A3 (de) | VERFAHREN ZUR HERSTELLUNG VON (R)- ODER (S)-HYDROXY-η-BUTYROLACTON | |
TR200001161A2 (tr) | 8-Siklopentil-6-etil-3-[ikame edilmiş]-5, 8-Dihidro-4H-1, 2, 3A, 7, 8-Pentaaza-As-Indasenlerin hazırlandığı işlem ve burada yararlı ara bağlar. | |
ATE329917T1 (de) | 1h-pyrrolo 1,2-bö 1,2,4ötriazolederivate, zwischenprodukte und verfahren zur herstellung von 1h-1,2,4,-triazol-5-yl essigsäureesterderivate | |
DE69913736D1 (de) | Siastatin derivate mit glycosidase inhinbor-aktivität und ein verfahren zur herstellung derselben |